Continuing Education Activity

Incomplete pregnancy loss, also known as incomplete miscarriage or incomplete abortion, is the partial loss of products of conception within the first 20 weeks of gestation. Incomplete miscarriage presents with moderate to severe vaginal bleeding, sometimes with the noticeable passage of tissue, that is typically associated with lower abdominal and pelvic pain. Diagnosis is made primarily through visualizing pregnancy tissue in the cervical os during a speculum examination. An ultrasound finding of heterogeneous or echogenic tissue within the endometrial canal in a patient with the characteristic clinical features of a miscarriage or the expulsion of products of conception that is less than generally expected for a given gestational age also supports a diagnosis of incomplete pregnancy loss. Management options include expectant, medical, and surgical treatments, although expectant management alone is often highly successful. Proper diagnosis and treatment with close obstetric follow-up and patient education are essential to prevent serious complications. This activity for healthcare professionals is designed to enhance the learner's competence when managing incomplete pregnancy loss, equipping them with updated knowledge, skills, and strategies for timely identification, effective interventions, and improved care coordination, leading to better patient outcomes and reduced maternal morbidity.

Objectives:

• Identify the clinical features of incomplete pregnancy loss and characteristic findings on imaging studies.
• Assess patients presenting with first-trimester bleeding and cramping.
• Differentiate incomplete miscarriage from other etiologies of first-trimester bleeding.
• Select the appropriate management approaches for incomplete pregnancy loss.

Introduction

The gestational ages and classifications professional organizations use to categorize miscarriages differ in terminology. Currently, the gestational age divisions for various pregnancy loss terms, particularly internationally, are not well defined. Traditionally in the US, however, a "miscarriage," sometimes termed a "spontaneous abortion," is defined as a spontaneous loss of a nonviable intrauterine pregnancy within the first 20 weeks of gestation; a fetal demise after 20 weeks of gestation is generally termed a "stillbirth" or "intrauterine fetal demise."[1][2] An "early miscarriage" or "early pregnancy loss" commonly refers to a loss occurring before 10 to 13 weeks of gestation.[3][4] The term "incomplete miscarriage," also known as an "incomplete pregnancy loss" or "incomplete spontaneous abortion," is generally defined as a specific subtype of miscarriage in which the products of conception (POC) have not been completely expelled from the uterus.[4][3]

The term "inevitable miscarriage" was sometimes used by clinicians to characterize a miscarriage in which the cervical os is open, and symptoms of vaginal bleeding and pelvic cramping are present; however, no POC have been expelled. In an incomplete pregnancy loss, though the cervical os is also open and vaginal bleeding and cramping are also present, there is partial, but not yet complete, expulsion of the POC. Differentiating these two traditional subtypes can be difficult, and they have no significant prognostic or management differences. For this reason, many clinicians prefer not to use the term "inevitable miscarriage."[5][2]

The overall incidence of spontaneous pregnancy loss is 10% to 15% in clinically recognized pregnancies. The incidence of incomplete pregnancy loss has not been well studied; however, the incidence of incomplete second-trimester abortions following surgical and medical modalities is 1% and 8%, respectively.[5][6] The etiology of any spontaneous pregnancy loss is often unknown, but up to 50% of cases are thought to be due to fetal chromosomal abnormalities.[4] 

An incomplete miscarriage is typically diagnosed with a history, physical exam, and pelvic ultrasound; at early gestational ages, a β-human chorionic gonadotropin (β-hCG) level may also be indicated to make a proper diagnosis. Patients with an incomplete miscarriage typically present with vaginal bleeding, lower abdominopelvic pain or cramping, and an open cervical os before 20 weeks of gestation. Incomplete miscarriage should be differentiated from a threatened miscarriage, which refers to a pregnancy complicated by vaginal bleeding with a closed cervical os that is found to be viable on ultrasound, and a complete miscarriage in which all the POC have been expelled from the uterus, and the cervix has closed again. Other differential diagnoses should also be excluded (eg, ectopic pregnancy, molar pregnancy, and nonobstetric causes of bleeding).[2] 

Management options include expectant, medical, and surgical treatments, although expectant management alone is often highly successful.[5][7][8] Complications, such as sepsis from retained POC, hemorrhagic shock, or cervical shock, are rare but can be severe. The prognosis for these patients is generally good, with proper diagnosis, close obstetric follow-up, and patient education.

Etiology

A specific cause for incomplete expulsion of POC is unclear; however, it may potentially occur following any spontaneous miscarriage or induced abortion.[5][7] Historically, all miscarriages were considered incomplete until uterine curettage confirmed complete expulsion of POC.[5]

Various potential etiologies may result in spontaneous asymptomatic, incomplete, or complete miscarriage. Early pregnancy loss is due to embryonic chromosomal abnormalities in about 50% of cases.[9] Other risk factors include maternal age, maternal comorbidities, especially diabetes, hypertension, renal disease, thyroid disorders, celiac disease, systemic lupus erythematosus (SLE), antiphospholipid syndrome, extremes of weight, structural uterine abnormalities, teratogen exposure (eg, drugs, alcohol, or radiation), some infections (eg, parvovirus B19, syphilis, or Listeria monocytogenes), and trauma.[10][11][12][13] Congenital anomalies and genetic syndromes can also result in miscarriage. 

It is also possible for an induced abortion to result in incomplete passage of POC, similar to a spontaneous incomplete miscarriage.[5] Unsafe abortion may increase the risk of incomplete abortion.[14] Unsafe abortion is defined by the World Health Organization (WHO) as an abortion performed by people lacking the necessary skills or in an environment lacking the minimum medical standards, or both; other definitions also include the use of hazardous techniques, such as ingesting toxic substances, abdominal trauma, and intrauterine instrumentation.[15][16]

Epidemiology

By definition, incomplete pregnancy loss occurs in women with a gestational age of <20 weeks. When all subtypes of miscarriage are considered together, miscarriage occurs in an estimated 10% to 15% of clinically recognized pregnancies; the specific incidence of incomplete miscarriage has not been well documented.[5] In one study, 34% of anembryonic gestations had incomplete expulsion of POC after 1 month, and 26% of pregnancies with embryonic demise managed expectantly did not have complete expulsion of POC after 1 month.[2]

History and Physical

Clinical History

A thorough history should be obtained that includes medical conditions and obstetric and gynecologic history (eg, previous miscarriages, known uterine anomalies, and the first day of the last menstrual period [LMP]) to identify risk factors and patient-specific issues that may affect management.[7] Clinicians should review any previous ultrasounds from the current gestation and compare them with the calculated estimated due date (EDD) from a sure LMP to determine an accurate estimated gestational age, which can influence the preferred treatment modality.[2]

Additionally, clinicians should inquire about presenting symptoms such as cramping and pelvic pain and the quality and quantity of vaginal bleeding noted, including onset, number of saturated pads or tampons per hour, and the number and size of clots present.[2] Clinical features characteristic of incomplete pregnancy loss include the passage of clots or tissue, though it is certainly possible for patients to either be unaware of tissue expulsion that has occurred or mistake blood clot for tissue. Bleeding with an incomplete miscarriage is often prolonged and heavier than typical menses; heavy bleeding is frequently defined as soaking 1 to 2 menstrual pads per hour for 2 hours.[4] Reports of minimal bleeding and identified tissue following a medical or surgical abortion may also indicate an incomplete abortion.[7] Similarly, pain or discomfort should be characterized as this often varies with each individual. With an incomplete pregnancy loss, the pain is often described as severe menstrual cramping that is not resolving.[2] Patient anxiety can also increase the amount of pain experienced.[2]

Physical Examination 

An initial assessment of the patient's hemodynamic stability should include vital signs and a focused physical examination. Findings of hypovolemia (eg, tachycardia and hypotension) are suggestive of hemorrhage secondary to heavy uterine bleeding.[2] A fever is concerning for infection and possible septic miscarriage, which requires emergent obstetrical consultation and surgical intervention.[7][17]

On pelvic examination, typical findings of an incomplete pregnancy loss include an open cervical os with POC visible within the vaginal vault or protruding from the cervix.[2] The presence of purulent vaginal discharge and uterine tenderness strongly suggests infection. The vagina and vulva should also be carefully examined to rule out any nonobstetric causes of bleeding, such as vaginal trauma or bleeding polyps.[7][2][7]

The abdominal exam is typically benign; however, if peritoneal signs are present (eg, rebound tenderness, guarding, and rigidity), obstetrical or general surgery specialists should be consulted, and further evaluation should be emergently performed.[2]

Evaluation

Diagnostic Imaging 

Early pregnancy is best visualized using transvaginal ultrasound; therefore, this modality is preferred when evaluating a suspected pregnancy loss.[18] 

An incomplete pregnancy loss can be confirmed by a transvaginal ultrasound demonstrating the partial expulsion of POC and heterogeneous or echogenic contents within the endometrial cavity or endocervical canal in patients with an open cervical os, particularly if an intrauterine pregnancy was previously diagnosed by ultrasound imaging.[19][18][2] Additional findings on transvaginal ultrasound consistent with retained POC include a mass or focal thickening within the endometrium; occasionally, blood flow can be visualized within this area using Doppler imaging.[18] A nonviable pregnancy noted on imaging with persistent β-human chorionic gonadotropin (β-hCG) levels also suggests an incomplete pregnancy loss.[18]

If no previous imaging studies have established a viable intrauterine pregnancy for comparison, a nonviable pregnancy can be diagnosed with 100% specificity with a single transvaginal ultrasound demonstrating an intrauterine fetal crown-to-rump length of >7 mm without fetal heart tones or if no embryo is noted within a gestational sac with an average diameter of >25 mm.[17]  There is no consensus on transvaginal ultrasound findings indicative of a completed miscarriage; however, the absence of a gestational sac and an endometrial thickness of <30 mm is often used in studies.[4]

Diagnostic Laboratory Studies

The following laboratory studies should be performed to assist in patient management decisions.

β-hCG: The diagnosis of incomplete pregnancy loss is primarily based on clinical assessment and pelvic ultrasound; however, quantitative serum β-human chorionic gonadotropin (β-hCG) levels may be helpful in the diagnostic evaluation of patients without an accurate gestational age due to an unsure LMP or that are found to have a pregnancy of unknown location.[2][20] 

An intrauterine pregnancy typically can be expected to be visible on ultrasound at around 5 to 6 weeks of gestation. However, if the gestational age of a pregnancy is uncertain, a β-hCG level can help a clinician interpret pelvic ultrasound findings.[20] Traditionally, a β-hCG level of 1,000 to 2,000 mIU/mL was used as the "discriminatory zone" at which an intrauterine pregnancy could be visualized by transvaginal ultrasound; if not seen, either ectopic pregnancy or early pregnancy loss was likely. Recently, some studies have recommended that a β-hCG level of >3,500 mIU/mL would be more appropriate as normal intrauterine pregnancies are still possible below that level.[20]

A pregnancy of unknown location refers to a pregnant patient in whom a pelvic ultrasound study does not definitively demonstrate an intrauterine or ectopic pregnancy. In stable patients, β-hCG levels, which increase at a predictable rate in early pregnancy until plateauing at around 10 weeks of gestation, should be followed over several days to observe the trend. A slow increase or decrease in the β-hCG level before its plateau can indicate a failing or abnormal pregnancy.[21][20] It should be noted that ectopic pregnancies may have β-hCG levels that decrease before increasing again, and they can rupture even while β-hCG levels are decreasing. 

A β-hCG level is not diagnostic in itself and should always be interpreted with caution within the larger clinical context to avoid misdiagnosis; whenever the diagnosis of a hemodynamically stable patient is unclear, repeating ultrasound imaging and serial β-hCG levels, typically every 48 hours, are indicated.[18][20]

Hemoglobin and hematocrit: Due to the heavy amount of bleeding typical in most symptomatic patients, assessment for acute blood loss anemia should be performed at the initial presentation.[2]

Blood type with Rh(D) status: A possible transfusion may need to be performed, or Rh(D)-immune globulin administered in Rh(D)-negative patients; therefore, blood typing and Rh(D) status should be obtained with initial laboratory studies.[2]

Pathology studies: Any pregnancy tissue removed from the vagina vault or expelled should be sent for histological examination to confirm pregnancy loss and assess for a molar pregnancy.[17]

Sepsis laboratory studies: For patients where a septic incomplete miscarriage or abortion is suspected, additional laboratory evaluation is indicated, including complete blood count with a differential, comprehensive metabolic panel, serum lactate, blood and urine cultures, and endocervical cultures.[22]

Treatment / Management

Approach to Management 

Early pregnancy loss can generally be managed with expectant, medical, or surgical approaches.[5] Although clinicians traditionally used surgical management in most patients with incomplete pregnancy loss, current US guidelines from the American College of Obstetricians and Gynecologists (ACOG) state that patients with early pregnancy loss can be offered all three approaches (ie, expectant, medical, and surgical) as first-line options and that patient preference should guide management.[4] On the other hand, some guidelines, including those from the National Institutes of Health and Care Excellence (NICE) in the UK, more explicitly prefer 1 to 2 weeks of expectant management as the first-line approach in patients without contraindications. However, NICE guidelines note that medical management should be offered if the patient declines expectant management.[23] In patients with incomplete pregnancy loss, limited evidence suggests that medical management may not be any more beneficial than expectant management. Depending on clinical and patient factors, any of these approaches can be appropriate.[5] 

Expectant and Medical Management

Expectant management consists of the watchful monitoring of patients without contraindications to this approach, allowing the natural process of miscarriage to progress spontaneously if the patient remains stable and shows no evidence of infection. It has a high success rate in patients with first-trimester incomplete miscarriage, with up to 53% of patients having complete expulsion of POC within 1 week without additional medical or surgical treatment, compared to 30% of asymptomatic patients with embryonic demise.[19]  A Cochrane review found that expectant and medical management were equally effective.[5] However, with an expectant approach, it may take longer for POC to be expelled. Other methods should be offered when the patient decides not to continue expectant management.[19] Therefore, ACOG states that "there is insufficient evidence to support or refute the use of misoprostol among women with incomplete pregnancy loss."[4] 

If medical management is selected, ACOG recommends vaginal misoprostol 800 mcg once initially, with a potential second dose between 3 hours and 7 days later.[4] The World Health Organization prefers misoprostol regimens of 400 mcg sublingually once or 600 mcg orally only once for pregnancies <14 weeks of gestation.[7] One large study of women with incomplete abortion showed that the rate of complete abortion within 14 to 28 days of initial treatment with misoprostol without surgical intervention was 96.2%.[24]

With either approach, patients should be counseled to expect heavy bleeding and cramping, often greater than what is experienced with typical menses.[4] Symptoms tend to improve after the POC have been expelled, though some scant to moderate bleeding may last for several weeks. All patients should be instructed to seek medical care if they are soaking 2 pads per hour for ≤2 consecutive hours or if they develop dizziness, lightheadedness, or a fever.[4]

Appropriate analgesics should also be offered. Nonsteroidal anti-inflammatory drugs (NSAIDs) and acetaminophen or paracetamol are typically considered first-line agents, though some patients may require additional medications for a short time. Unless there is an infection, antibiotics are not indicated.

Patients should also have a follow-up plan to ensure the safe completion of the miscarriage. NICE guidelines recommend instructing the patient to take a home urine pregnancy test 3 weeks after bleeding and pain resolve and to return for evaluation if it is positive or if symptoms do not resolve after 2 weeks of expectant management. ACOG states a scheduled follow-up appointment with a repeat ultrasound to ensure complete expulsion of the gestational sac or serial serum β-hCG measurements in areas where ultrasound is unavailable should be performed. Patients with persistent POC, despite expectant or medical management, should be offered surgical management.[4][23]

Surgical Management

Surgical management for incomplete pregnancy loss is indicated in patients with hemodynamic instability, those at high risk for hemorrhage or with septic miscarriages, and people who failed expectant or medical management.[4] Additionally, surgical management is also preferred in those who cannot tolerate large drops in hemoglobin (eg, severe anemia, certain cardiovascular diseases). Results from a randomized controlled trial of 652 women with early pregnancy failure showed that when compared to surgical management, medical management was associated with heavier and more prolonged bleeding and a higher risk of a drop in hemoglobin >2 g/dL.[25] Surgical management is typically considered "definitive treatment" and, if selected, can be accomplished via uterine aspiration or suction curettage in either an operating room or, if clinically appropriate, an outpatient setting under local anesthesia. A dose of prophylactic antibiotics, doxycycline 200 mg intravenously once 1 hour before the procedure, is typically recommended.[4]

Rh(D)-immune Globulin

Rh(D)-immune globulin can be given to Rh-negative patients to prevent alloimmunization. Its use is consistently recommended after surgical management but is more controversial with expectant or medical management of pregnancy loss in the first trimester. 

ACOG states, "Although the risk of alloimmunization is low, the consequences can be significant, and administration of Rh(D)-immune globulin should be considered in cases of early pregnancy loss, especially those later in the first trimester."[25] In many places throughout the US, universal prophylaxis is standard, even in the first trimester. In the UK, NICE guidelines explicitly recommend against its use after expectant or medical management of miscarriage before 12 weeks of gestation.[23] Conversely, the British Committee for Standards in Haematology (BCSH), supported by the Royal College of Obstetricians and Gynaecologists (RCOG), does consider its use appropriate before 12 weeks when uterine bleeding is "repeated, heavy, or associated with abdominal pain," which would be the case in almost all patients with incomplete miscarriage.[26] Given these varying recommendations, regional and institutional protocols should guide management, if available.

A dose of Rh(D)-immune globulin 50 to 120 mcg intramuscularly once in the first trimester is typically recommended. After 12 weeks of gestation, ACOG guidelines recommend a dose of 300 mcg intramuscularly once, though the guidelines of some other countries recommend lower doses depending on the situation.[27][26]

Differential Diagnosis

In addition to incomplete miscarriage, the differential diagnosis for vaginal bleeding in pregnancy includes:

• Ectopic pregnancy
• Complete miscarriage
• Threatened miscarriage
• Subchorionic hemorrhage or hematoma
• Molar pregnancy
• Nonobstetric bleeding (eg, vaginal or cervical trauma, malignancy, or polyps)
• Infection of the vagina or cervix (eg, candidiasis, bacterial vaginosis, and Chlamydia trachomatis)[28] 
• Septic abortion
• Hemorrhagic shock
• Cervical shock
• Uterine rupture[29]

Prognosis

Patients with incomplete pregnancy loss typically have a very good prognosis with expectant management; approximately 90% of patients have complete expulsion of POC within 4 weeks.[2] The prognosis with medical management is similar.[5] Surgical management is considered "definitive treatment," and similar to expectant and medical management, the prognosis is also excellent. Future fertility does not appear to be impacted. It is safe to attempt conception immediately following a miscarriage. Studies have shown that live birth rates are higher for conceptions occurring within the first 3 months following a pregnancy loss than those who postpone conception.[30][31]

Complications

The risk of complications appears similar across management strategies.[4] The primary complications of incomplete pregnancy loss in the first trimester include retained POC, hemorrhage potentially requiring a blood transfusion, disseminated intravascular coagulation, endometritis, and sepsis.[17] The risk of infection appears higher in low-income compared to high-income countries. If an infection develops, the provider should consider the possibility of a polymicrobial infection of retained POC, typically due to genital flora.[32] The risk of death, while possible, is negligible for uncomplicated miscarriages before 12 weeks. 

Patients may experience some adverse reactions to medical management, most commonly nausea, vomiting, and diarrhea.[33] Surgical management may be complicated by uterine perforation and anesthesia reactions. Limited evidence also suggests that surgical management may increase the risk of intrauterine adhesions, though this is more likely after sharp curettage or repeated procedures.[34] The risk of complications is also generally higher with second-trimester losses, including risks for hemorrhage, infection, cervical laceration, and pulmonary embolism with medical and surgical approaches to management. Although rare, uterine rupture has also been reported with medical management of losses in the second trimester.[6]

One rare complication unique to incomplete miscarriage is cervical shock. With cervical shock, POC within the cervical canal can lead to excessive vagal stimulation, resulting in bradycardia and hypotension that does not respond to IV fluids.[35] In this situation, the POC should be immediately removed from the cervix, which can usually be accomplished easily using ring forceps or a similar type of instrument during a speculum exam; transfer to the operating suite and sedation are not necessary in most cases and may instead delay this definitive treatment.[35]

Consultations

A patient who presents to an emergency department with unstable vital signs and heavy bleeding will need emergent obstetric evaluation and possible intervention. Stable patients require follow-up with obstetric clinicians to confirm the completion of the miscarriage and to receive family planning counseling (eg, contraceptive or preconception counseling). Patients with recurrent pregnancy loss can be referred to a reproductive endocrinology and infertility (REI) specialist. Patients may also be referred to mental health or other emotional support services, as feelings of grief, guilt, and depression are common following pregnancy loss; however, this should be done individually as there has not been definitive evidence of improvement in patient outcomes.[2]

Deterrence and Patient Education

Patients should not delay seeking medical care if they experience bleeding during pregnancy, as this can lead to increased morbidity and mortality.[36] After a woman is evaluated by a healthcare professional and diagnosed with incomplete pregnancy loss, patients should be counseled on the risks and benefits of each management approach; joint decision-making between the patient and provider can then be used to select a treatment modality.[4]

Following treatment, patients should be counseled to expect to continue bleeding for 1 to 2 weeks, sometimes longer, particularly with expectant management. Clinicians should also provide patients precautions, instructing them to return for evaluation if bleeding is heavy enough to soak through 1 to 2 pads per hour for 2 consecutive hours, if the pain is uncontrolled by over-the-counter analgesics, or if a fever develops. Patients should also be scheduled for follow-up to confirm the complete expulsion of POC from the uterus. Typically this is done with a pelvic ultrasound; however, a decrease in β-hCG levels by 50% after 2  days or 87% by 7 days may also be used if ultrasound is unavailable.[2]  Patients can also be reassured that uncomplicated pregnancy loss does not impact future fertility. Additionally, ovulation often resumes within the first cycle after the expulsion of fetal tissues, so patients should be offered contraception if they do not desire another pregnancy right away.[37]

Pearls and Other Issues

• An incomplete miscarriage is primarily diagnosed when POC are visible within the cervical canal or vaginal vault on examination. 
• Expectant management is highly effective in these patients. It is unclear if medical management adds any benefit, but it can be offered if the patient desires.
• Surgical management is indicated in patients with hemodynamic instability, signs of infection, patients who cannot tolerate a significant drop in hemoglobin, and those who have failed expectant or medical management. According to some guidelines, including those from the US, surgical management is also appropriate as a first-line treatment option if the patient desires.
• Patients with pregnancy loss tend to have better mental health outcomes if they can choose their treatment plans. Women who were managed according to their preference (ie, expectant, medical, or surgical management) had better mental health outcomes than their cohorts who were randomized to either expectant or surgical management after 12 weeks.[38]
• A patient presenting with vaginal bleeding in early pregnancy, hypotension, and bradycardia may have cervical shock from vagal stimulation secondary to the persistent presence of POC in the endocervical canal. Symptoms can improve rapidly by removing the POC from the cervical canal with ring forceps or a similar instrument on a bedside speculum exam.

Enhancing Healthcare Team Outcomes

The management of patients with incomplete pregnancy loss can involve a wide range of healthcare professionals across multiple disciplines, including physicians (eg, obstetricians, emergency medicine and family medicine physicians, and radiologists), advanced practice nurses, physician assistants, nursing staff, pharmacists, and radiology, laboratory, and pharmacy technicians. Management consultation between emergency, radiology, and obstetric clinicians, patient counseling and provision of prescriptions, and coordination of follow-up care all require interprofessional communication and cooperation. Patients may also struggle with mental health and spiritual concerns related to pregnancy loss, so mental health professionals, chaplains, and grief counselors may also play an essential role in enhancing patient outcomes.[39] Clinical and nonclinical staff should be trained to communicate sensitively with women experiencing early pregnancy complications.[40]

Review Questions

• Access free multiple choice questions on this topic.
• Click here for a simplified version.
• Comment on this article.

References

1.

Management of Stillbirth: Obstetric Care Consensus No, 10. Obstet Gynecol. 2020 Mar;135(3):e110-e132. [PubMed: 32080052]

2.

Hendriks E, MacNaughton H, MacKenzie MC. First Trimester Bleeding: Evaluation and Management. Am Fam Physician. 2019 Feb 01;99(3):166-174. [PubMed: 30702252]

3.

Kolte AM, Bernardi LA, Christiansen OB, Quenby S, Farquharson RG, Goddijn M, Stephenson MD., ESHRE Special Interest Group, Early Pregnancy. Terminology for pregnancy loss prior to viability: a consensus statement from the ESHRE early pregnancy special interest group. Hum Reprod. 2015 Mar;30(3):495-8. [PubMed: 25376455]

4.

American College of Obstetricians and Gynecologists' Committee on Practice Bulletins—Gynecology. ACOG Practice Bulletin No. 200: Early Pregnancy Loss. Obstet Gynecol. 2018 Nov;132(5):e197-e207. [PubMed: 30157093]

5.

Kim C, Barnard S, Neilson JP, Hickey M, Vazquez JC, Dou L. Medical treatments for incomplete miscarriage. Cochrane Database Syst Rev. 2017 Jan 31;1(1):CD007223. [PMC free article: PMC6464743] [PubMed: 28138973]

6.

ACOG Practice Bulletin No. 135: Second-trimester abortion. Obstet Gynecol. 2013 Jun;121(6):1394-1406. [PubMed: 23812485]

7.

Abortion care guideline [Internet]. World Health Organization; Geneva: 2022. [PubMed: 35344310]

8.

Medical management of abortion. World Health Organization; Geneva: 2018. [PubMed: 30702834]

9.

Levy B, Sigurjonsson S, Pettersen B, Maisenbacher MK, Hall MP, Demko Z, Lathi RB, Tao R, Aggarwal V, Rabinowitz M. Genomic imbalance in products of conception: single-nucleotide polymorphism chromosomal microarray analysis. Obstet Gynecol. 2014 Aug;124(2 Pt 1):202-209. [PubMed: 25004334]

10.

Practice Committee of the American Society for Reproductive Medicine. Evaluation and treatment of recurrent pregnancy loss: a committee opinion. Fertil Steril. 2012 Nov;98(5):1103-11. [PubMed: 22835448]

11.

Metwally M, Ong KJ, Ledger WL, Li TC. Does high body mass index increase the risk of miscarriage after spontaneous and assisted conception? A meta-analysis of the evidence. Fertil Steril. 2008 Sep;90(3):714-26. [PubMed: 18068166]

12.

Maraka S, Ospina NM, O'Keeffe DT, Espinosa De Ycaza AE, Gionfriddo MR, Erwin PJ, Coddington CC, Stan MN, Murad MH, Montori VM. Subclinical Hypothyroidism in Pregnancy: A Systematic Review and Meta-Analysis. Thyroid. 2016 Apr;26(4):580-90. [PMC free article: PMC4827301] [PubMed: 26837268]

13.

Xiong YQ, Tan J, Liu YM, He Q, Li L, Zou K, Sun X. The risk of maternal parvovirus B19 infection during pregnancy on fetal loss and fetal hydrops: A systematic review and meta-analysis. J Clin Virol. 2019 May;114:12-20. [PubMed: 30897374]

14.

Othieno C, Babigumira JB, Richardson B. Are women with complications of an incomplete abortion more likely to be HIV infected than women without complications? BMC Womens Health. 2015 Oct 26;15:95. [PMC free article: PMC4624175] [PubMed: 26503499]

15.

Ganatra B, Tunçalp Ö, Johnston HB, Johnson BR, Gülmezoglu AM, Temmerman M. From concept to measurement: operationalizing WHO's definition of unsafe abortion. Bull World Health Organ. 2014 Mar 01;92(3):155. [PMC free article: PMC3949603] [PubMed: 24700971]

16.

Fawcus SR. Maternal mortality and unsafe abortion. Best Pract Res Clin Obstet Gynaecol. 2008 Jun;22(3):533-48. [PubMed: 18249585]

17.

Quinley KE, Chong D, Prager S, Wills CP, Nagdev A, Kennedy S. Manual Uterine Aspiration: Adding to the Emergency Physician Stabilization Toolkit. Ann Emerg Med. 2018 Jul;72(1):86-92. [PubMed: 29248332]

18.

Expert Panel on Women’s Imaging: Brown DL, Packard A, Maturen KE, Deshmukh SP, Dudiak KM, Henrichsen TL, Meyer BJ, Poder L, Sadowski EA, Shipp TD, Simpson L, Weber TM, Zelop CM, Glanc P. ACR Appropriateness Criteria^® First Trimester Vaginal Bleeding. J Am Coll Radiol. 2018 May;15(5S):S69-S77. [PubMed: 29724428]

19.

Prine LW, MacNaughton H. Office management of early pregnancy loss. Am Fam Physician. 2011 Jul 01;84(1):75-82. [PubMed: 21766758]

20.

American College of Obstetricians and Gynecologists' Committee on Practice Bulletins—Gynecology. ACOG Practice Bulletin No. 193: Tubal Ectopic Pregnancy. Obstet Gynecol. 2018 Mar;131(3):e91-e103. [PubMed: 29470343]

21.

Barnhart KT, Guo W, Cary MS, Morse CB, Chung K, Takacs P, Senapati S, Sammel MD. Differences in Serum Human Chorionic Gonadotropin Rise in Early Pregnancy by Race and Value at Presentation. Obstet Gynecol. 2016 Sep;128(3):504-511. [PMC free article: PMC4993627] [PubMed: 27500326]

22.

Udoh A, Effa EE, Oduwole O, Okusanya BO, Okafo O. Antibiotics for treating septic abortion. Cochrane Database Syst Rev. 2016 Jul 01;7(7):CD011528. [PMC free article: PMC6458041] [PubMed: 27364644]

23.

Rafi J, Khalil H. Expectant management of miscarriage in view of NICE Guideline 154. J Pregnancy. 2014;2014:824527. [PMC free article: PMC4020214] [PubMed: 24868466]

24.

Klingberg-Allvin M, Cleeve A, Atuhairwe S, Tumwesigye NM, Faxelid E, Byamugisha J, Gemzell-Danielsson K. Comparison of treatment of incomplete abortion with misoprostol by physicians and midwives at district level in Uganda: a randomised controlled equivalence trial. Lancet. 2015 Jun 13;385(9985):2392-8. [PubMed: 25817472]

25.

Davis AR, Hendlish SK, Westhoff C, Frederick MM, Zhang J, Gilles JM, Barnhart K, Creinin MD., National Institute of Child Health and Human Development Management of Early Pregnancy Failure Trial. Bleeding patterns after misoprostol vs surgical treatment of early pregnancy failure: results from a randomized trial. Am J Obstet Gynecol. 2007 Jan;196(1):31.e1-7. [PubMed: 17240222]

26.

Qureshi H, Massey E, Kirwan D, Davies T, Robson S, White J, Jones J, Allard S., British Society for Haematology. BCSH guideline for the use of anti-D immunoglobulin for the prevention of haemolytic disease of the fetus and newborn. Transfus Med. 2014 Feb;24(1):8-20. [PubMed: 25121158]

27.

Practice Bulletin No. 181: Prevention of Rh D Alloimmunization. Obstet Gynecol. 2017 Aug;130(2):e57-e70. [PubMed: 28742673]

28.

Griebel CP, Halvorsen J, Golemon TB, Day AA. Management of spontaneous abortion. Am Fam Physician. 2005 Oct 01;72(7):1243-50. [PubMed: 16225027]

29.

Birch JD, Gulati D, Mandalia S. Cervical shock: a complication of incomplete abortion. BMJ Case Rep. 2017 Jul 14;2017 [PMC free article: PMC5535053] [PubMed: 28710197]

30.

Sundermann AC, Hartmann KE, Jones SH, Torstenson ES, Velez Edwards DR. Interpregnancy Interval After Pregnancy Loss and Risk of Repeat Miscarriage. Obstet Gynecol. 2017 Dec;130(6):1312-1318. [PMC free article: PMC5709156] [PubMed: 29112656]

31.

Schliep KC, Mitchell EM, Mumford SL, Radin RG, Zarek SM, Sjaarda L, Schisterman EF. Trying to Conceive After an Early Pregnancy Loss: An Assessment on How Long Couples Should Wait. Obstet Gynecol. 2016 Feb;127(2):204-12. [PMC free article: PMC4780347] [PubMed: 26942344]

32.

Rouse CE, Eckert LO, Muñoz FM, Stringer JSA, Kochhar S, Bartlett L, Sanicas M, Dudley DJ, Harper DM, Bittaye M, Meller L, Jehan F, Maltezou HC, Šubelj M, Bardaji A, Kachikis A, Beigi R, Gravett MG., Global Alignment of Immunization Safety in Pregnancy (GAIA) Postpartum Endometritis, Infection following Incomplete or Complete Abortion Work Group. Postpartum endometritis and infection following incomplete or complete abortion: Case definition & guidelines for data collection, analysis, and presentation of maternal immunization safety data. Vaccine. 2019 Dec 10;37(52):7585-7595. [PMC free article: PMC6891249] [PubMed: 31783980]

33.

Zhang J, Gilles JM, Barnhart K, Creinin MD, Westhoff C, Frederick MM., National Institute of Child Health Human Development (NICHD) Management of Early Pregnancy Failure Trial. A comparison of medical management with misoprostol and surgical management for early pregnancy failure. N Engl J Med. 2005 Aug 25;353(8):761-9. [PubMed: 16120856]

34.

Tam WH, Lau WC, Cheung LP, Yuen PM, Chung TK. Intrauterine adhesions after conservative and surgical management of spontaneous abortion. J Am Assoc Gynecol Laparosc. 2002 May;9(2):182-5. [PubMed: 11960045]

35.

Kyejo W, Moshi B, Kapesi V, Ntiyakunze G, Gidion D, Kaguta M. Cervical vasovagal shock: A rare complication of incomplete abortion case report. Int J Surg Case Rep. 2022 Aug;97:107455. [PMC free article: PMC9403285] [PubMed: 35907297]

36.

Gebretsadik A. Factors Associated with Management Outcome of Incomplete Abortion in Yirgalem General Hospital, Sidama Zone, Southern Ethiopia. Obstet Gynecol Int. 2018;2018:3958681. [PMC free article: PMC6171250] [PubMed: 30327673]

37.

Gemzell-Danielsson K, Kopp Kallner H, Faúndes A. Contraception following abortion and the treatment of incomplete abortion. Int J Gynaecol Obstet. 2014 Jul;126 Suppl 1:S52-5. [PubMed: 24739476]

38.

Wieringa-De Waard M, Hartman EE, Ankum WM, Reitsma JB, Bindels PJ, Bonsel GJ. Expectant management versus surgical evacuation in first trimester miscarriage: health-related quality of life in randomized and non-randomized patients. Hum Reprod. 2002 Jun;17(6):1638-42. [PubMed: 12042291]

39.

Kong GW, Lok IH, Yiu AK, Hui AS, Lai BP, Chung TK. Clinical and psychological impact after surgical, medical or expectant management of first-trimester miscarriage--a randomised controlled trial. Aust N Z J Obstet Gynaecol. 2013 Apr;53(2):170-7. [PubMed: 23488984]

40.

Ectopic pregnancy and miscarriage: diagnosis and initial management. National Institute for Health and Care Excellence (NICE); London: Aug 23, 2023. [PubMed: 31393678]

Disclosure: Ashley Redinger declares no relevant financial relationships with ineligible companies.

Disclosure: Hao Nguyen declares no relevant financial relationships with ineligible companies.